Literature DB >> 29481278

Multiplet of Skyrmion States on a Curvilinear Defect: Reconfigurable Skyrmion Lattices.

Volodymyr P Kravchuk1,2, Denis D Sheka3, Attila Kákay4, Oleksii M Volkov4, Ulrich K Rößler2, Jeroen van den Brink2,5, Denys Makarov4, Yuri Gaididei1.   

Abstract

Typically, the chiral magnetic Skyrmion is a single-state excitation. Here we propose a system, where multiplet of Skyrmion states appears and one of these states can be the ground one. We show that the presence of a localized curvilinear defect drastically changes the magnetic properties of a thin perpendicularly magnetized ferromagnetic film. For a large enough defect amplitude a discrete set of equilibrium magnetization states appears forming a ladder of energy levels. Each equilibrium state has either a zero or a unit topological charge; i.e., topologically trivial and Skyrmion multiplets generally appear. Transitions between the levels with the same topological charge are allowed and can be utilized to encode and switch a bit of information. There is a wide range of geometrical and material parameters, where the Skyrmion level has the lowest energy. Thus, periodically arranged curvilinear defects can result in a Skyrmion lattice as the ground state.

Year:  2018        PMID: 29481278     DOI: 10.1103/PhysRevLett.120.067201

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  3 in total

1.  Intrinsic DMI-free skyrmion formation and robust dynamic behaviors in magnetic hemispherical shells.

Authors:  Jaehak Yang; Claas Abert; Dieter Suess; Sang-Koog Kim
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

2.  Nucleation and stability of skyrmions in three-dimensional chiral nanostructures.

Authors:  Yan Liu; Na Cai; Xingxing Yu; Shengjie Xuan
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

3.  Magnonic key based on skyrmion clusters.

Authors:  E Saavedra; F Tejo; N Vidal-Silva; J Escrig
Journal:  Sci Rep       Date:  2021-11-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.